慢性肠系膜缺血血管腔内或开放肠系膜血管重建失败后开放肠系膜旁路的比较结局
回顾2002至2022年佛罗里达大学145例开放肠系膜旁路手术,比较补救性开放肠系膜旁路(R-OMB,n=48)与初次开放肠系膜旁路(P-OMB,n=97)的结局。R-OMB组心脏和出血并发症率低于P-OMB组,30天死亡率、再干预率和生存率两组无差异。R-OMB不是死亡的预测因素。
要点
- R-OMB组心脏并发症率6% vs P-OMB组21%(P<.01),出血并发症率2% vs 15%(P=.01)。
- 30天死亡率总体7%(10/145),并发症率53%(77/145),两组无差异。
- R-OMB不是全因死亡的独立预测因素。
核心结论
- 对于腔内支架或既往开放旁路失败后的补救性开放肠系膜旁路,其围手术期和远期结局似乎与初次开放肠系膜旁路相当。
- 这些发现支持了近期更新的临床实践指南推荐,即对复发性慢性肠系膜缺血采用血管腔内优先策略,因为开放肠系膜旁路围手术期并发症风险显著。
- 然而,在肠系膜血管重建失败后被认为不适合腔内重建的患者亚组中,补救性开放肠系膜旁路的结果似乎可接受,并突显了该策略在选定患者中的效用。
研究设计与样本
- 回顾性分析2002年至2022年在佛罗里达大学接受开放肠系膜旁路手术的所有患者。
- 比较补救性开放肠系膜旁路(即既往血管腔内或开放肠系膜旁路失败史)与初次开放肠系膜旁路的结局。
- 共分析145例开放肠系膜旁路手术(补救性开放肠系膜旁路n=48[33%];初次开放肠系膜旁路n=97[67%])。
- 主要终点为30天死亡率,次要结局包括并发症、再干预和生存。
- 采用Kaplan-Meier法估计免于再干预率和全因死亡率,多变量Cox比例风险模型确定死亡预测因素。
主要发现
- 大多数补救性开放肠系膜旁路手术因支架失败而实施(既往血管腔内n=39[81%];既往开放旁路n=9[19%])。
- 补救性开放肠系膜旁路组患者更年轻(66±9岁 vs 初次开放肠系膜旁路组69±11岁;P=.09),吸烟暴露比例更低(29% vs 初次开放肠系膜旁路组48%;P=.07)。
- 补救性开放肠系膜旁路与较少的术中输血相关(0.6单位 vs 初次开放肠系膜旁路组1.4单位;P=.01)。
- 总体30天死亡率为7%(n=10/145),并发症率为53%(n=77/145),两组间无差异。
- 补救性开放肠系膜旁路组心脏并发症率降低(6% vs 初次开放肠系膜旁路组21%;P<.01),出血并发症率降低(2% vs 初次开放肠系膜旁路组15%;P=.01)。
关键数值与推荐
- 临床实践指南推荐对慢性肠系膜缺血患者采用血管腔内优先方法(ENDO),而对被认为不适合血管腔内候选者的受试者建议开放肠系膜旁路(OMB)。
- 近期更新的临床实践指南推荐对复发性慢性肠系膜缺血采用血管腔内优先策略。
临床怎么用
- 对于腔内支架或既往开放旁路失败后的补救性开放肠系膜旁路,围手术期和远期结局似乎与初次开放肠系膜旁路相当。
- 在肠系膜血管重建失败后被认为不适合腔内重建的患者亚组中,补救性开放肠系膜旁路的结果似乎可接受,并突显了该策略在选定患者中的效用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Clinical practice guidelines have recommended an endovascular-first approach (ENDO) for the management of patients with chronic mesenteric ischemia (CMI), whereas an open mesenteric bypass (OMB) is proposed for subjects deemed to be poor ENDO candidates. However, the impact of a previous failed endovascular or open mesenteric reconstruction on a subsequent OMB is unknown. Accordingly, this study was designed to examine the results of a remedial OMB (R-OMB) after a failed ENDO or a primary OMB (P-OMB) for patients with recurrent CMI. METHODS: All patients who underwent an OMB from 2002 to 2022 at the University of Florida were reviewed. Outcomes after an R-OMB (ie, history of a failed ENDO or P-OMB) and P-OMB were compared. The primary end point was 30-day mortality, whereas secondary outcomes included complications, reintervention, and survival. The Kaplan-Meier methodology was used to estimate freedom from reintervention and all-cause mortality, whereas multivariable Cox proportional hazards modeling identified predictors of death. RESULTS: A total of 145 OMB procedures (R-OMB, n = 48 [33%]; P-OMB, n = 97 [67%]) were analyzed. A majority of R-OMB operations were performed for a failed stent (prior ENDO, n = 39 [81%]; prior OMB, n = 9 [19%]). R-OMB patients were generally younger (66 ± 9 years vs P-OMB, 69 ± 11 years; P = .09) and had lower incidence of smoking exposure (29% vs P-OMB, 48%; P = .07); however, there were no other differences in demographics or comorbidities. R-OMB was associated with less intraoperative transfusion (0.6 units vs P-OMB, 1.4 units; P = .01), but there were no differences in conduit choice or bypass configuration.The overall 30-day mortality and complication rates were 7% (n = 10/145) and 53% (n = 77/145), respectively, with no difference between the groups. Notably, R-OMB had decreased cardiac (6% vs P-OMB, 21%; P < .01) and bleeding complication rates (2% vs P-OMB, 15%; P = .01). The freedom from reintervention (1 and 5 years: R-OMB: 95% ± 4%, 83% ± 9% vs P-OMB: 97% ± 2%, 93% ± 5%, respectively; log-rank P = .21) and survival (1 and 5 years: R-OMB: 82% ± 6%, 68% ± 9% vs P-OMB: 84% ± 4%, 66% ± 7%; P = .91) were similar. Independent predictors of all-cause mortality included new postoperative hemodialysis requirement (hazard ratio [HR], 7.4, 95% confidence interval [CI], 3.1-17.3; P < .001), pulmonary (HR, 2.7, 95% CI, 1.4-5.3; P = .004) and cardiac (HR, 2.4, 95% CI, 1.1-5.1; P = .04) complications, and female sex (HR, 2.1, 95% CI, 1.03-4.8; P = .04). Notably, R-OMB was not a predictor of death. CONCLUSIONS: The perioperative and longer-term outcomes for a remedial OMB after a failed intraluminal stent or previous open bypass appear to be comparable to a P-OMB. These findings support the recently updated clinical practice guideline recommendations for an endovascular-first approach to treating recurrent CMI due to the significant perioperative complication risk of OMB. However, among the subset of patients deemed ineligible for endoluminal reconstruction after failed mesenteric revascularization, R-OMB results appear to be acceptable and highlight the utility of this strategy in selected patients.
引用
- Jacobs CR, Scali ST, Jacobs BN, et al. Comparative outcomes of open mesenteric bypass after a failed endovascular or open mesenteric revascularization for chronic mesenteric ischemia. J Vasc Surg. 2024. PMID: 38552885. doi:10.1016/j.jvs.2024.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。